Last reviewed · How we verify
NCT04375995
The Prevalence Of Small Airways Dysfunction In Asthma Patients And The Impact On The Asthma Control
NA trial testing Impulse oscillometry in Asthma in 108 participants. Status unknown.
1 September 2020
Quick facts
| Lead sponsor | Sibel Naycı |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 108 |
| Start date | 1 October 2019 |
| Primary completion | 1 September 2020 |
| Estimated completion | 1 April 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Impulse oscillometry
- Spirometric pulmonary function test
- Fractional exhaled nitric oxide (FENO) test
- Thorax Computed Tomography
- Blood eosinophil level
- Asthma control test
- Asthma quality of life scale
- Chest X Ray
Conditions studied
- Asthma — all drugs for Asthma →
- Small Airway Disease — all drugs for Small Airway Disease →
Sponsor
Sibel Naycı
Who can join
18 and older, any sex, with Asthma or Small Airway Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Asthma, which are one of the most important causes of morbidity and mortality both in the world and in our country, constitute a very serious social and economic burden. An estimated 300 million people suffer from asthma worldwide, which is a major public health problem. Asthma is complex and heterogeneous chronic airway diseases that require a multifaceted approach. In asthma, small airways represent key regions of airflow obstruction. Although small airway dysfunction is known in chronic airway diseases, the importance of small airway dysfunction on disease control, exacerbations and quality of life, and the importance of taking place among treatable targets is not clear. Thus, there is an unmet need to assess its role in the control of the disease. Therefore, our primary aim in the study is to determine the frequency of small airway dysfunction measured by impulse oscillometry in Asthma patients. Our secondary aim is to evaluate the role of small airway dysfunction in disease severity, disease phenotypes, disease control, quality of life and its effect on predicting the risk of exacerbation and its role among treatable targets in Asthma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04375995
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Impulse oscillometry
Trials testing the same drug.
- NCT04384133 — The Prevalence of Small Airways Dysfunction In COPD Patients and The Impact on COPD Control · NA · unknown
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other Sibel Naycı trials
Trials by the same sponsor.
- NCT04384133 — The Prevalence of Small Airways Dysfunction In COPD Patients and The Impact on COPD Control · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04375995 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sibel Naycı
- Last refreshed: 6 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04375995.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing